HIMS
Bigger bag, bigger questions
Hims & Hers came back with a fatter-than-expected convertible note deal, pricing $350 million of senior unsecured notes due 2032 after initially planning to raise $300 million. That kind of upsizing usually screams, “the demand is there,” which is finance-speak for investors were willing to take a bigger bite than management first offered.
Why the Street is side-eyeing it
The notes carry a 0.00% coupon, so Hims isn’t paying cash interest along the way. Nice. But the tradeoff is the usual convertible-notes plot twist: if the stock rips higher later, holders can convert and existing shareholders can feel the dilution breeze.
To soften that blow, the company also put on capped call transactions with an initial cap price of $50.15 a share. Think of it like buying a little airbag for the stock chart.
What the money is for
Hims says the proceeds are meant to keep the business flexible and help fund international growth, including support for the proposed Eucalyptus acquisition, which is expected to close in mid-2026. So this isn’t just a “we need cash” move — it’s a “we want room to keep expanding” move.
That said, the market doesn’t hand out gold stars for ambition alone. A financing like this can still pressure the stock in the short run, especially when traders are already twitchy about dilution and the shares are sitting well below their recent highs.
Big picture: Hims is still playing offense, but this deal reminds investors that growth stories often come with a little extra financial luggage.